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Anesthetized guinea pigs were given arterial bolus injections of saline or varying nicotine concentrations. Blood flow through the 
cochlea and skin were measured via laser Doppler and arterial blood pressure via an arterial cannula. Cochlear blood flow increased 
with low doses of nicotine but decreased with the highest dose. while blood pressure increased and skin flow decreased with all doses 
of nicotine. Control injections of saline vehicle had only minor and transient effects. 
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Nicotine is a cholinomimetic agent and specifi- 
cally a ganglionic stimulating and blocking agent 
(Taylor, 1980; Voile and Koelle, 1970). As such it 
has a variety of neurologically mediated effects on 
the cardiovascular system. The effect of these 
nicotine induced cardiovascular changes on perfu- 
sion of the cochlear vasculature is not known. 
There appear, however, to be two basic mecha- 
nisms by which nicotine may affect cochlear blood 
flow (CBF). First, CBF may be altered secondary 
to systemic changes in cardiovascular parameters. 
Nicotine elevates heart rate, increases blood pres- 
sure and promotes peripheral vasoconstriction 
(Ague, 1973, 1974; Bobbin and Gondra, 1976; 
Cellina et al., 1975; Elliott and Thysell, 1968; 
Erwin, 1971; Myrsten et al., 1972; Nesbitt, 1973). 
Several authors have reported that CBF varies in 
proportion to systemic blood pressure (Goodwin 
et al., 1985; Miller et al., 1983, 1985; Snow and 
Suga, 1972; Suga and Snow, 1969). Wright et al. 
(1985) for example, reported that systemic blood 
pressure and cochlear blood flow both increased as 
a result of infusing angiotensin, an arterial vaso- 
constrictor. 
A second means by which nicotine may affect 
cochlear blood Bow is via regional or even local 
mechanisms. Such effects could conceivably occur 
directly or seondary to catecholamine release. Al- 
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though the relationship to CBF is not known, 
findings concerning the effects of nicotine on 
cerebral blood flow may be applicable. Hall (1972) 
has reported that nicotine elevated cerebral blood 
flow. He attributed such increases to local vasodi- 
lating mechanisms within the brain. More specifi- 
cally, Vatner et al. (1980) reported that a 0.2 
p&/kg dose of nicotine resulted first in elevated 
cerebral blood flow and velocity and then in a 
decrease. They attributed these changes to actions 
of the carotid chemoreceptors and the sympathetic 
nervous system. The later decrement in cerebral 
perfusion, however, was independent of mean 
arterial pressure which remained elevated, suggest- 
ing the possibility of local mechanisms. 
Despite the aforementioned indications that 
nicotine may influence CBF, no previous study, to 
our knowledge, has directly examined the effect of 
nicotine on CBF. The purpose of the present 
investigation was to measure nicotine induced 
changes in CBF via a laser Doppler flowmeter. 
Method 
Subjects 
The subjects for this experiment were 9 mature 
(approximately 1000 g) Hartley strain albino 
guinea pigs (Charles River). They were maintained 
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in group cages in a vivarium approved by the 
American Association for Laboratory Animal 
Care, with a 12 : 12 light/dark cycle initiated at 
0700 h, and a freely available nutritionally bal- 
anced diet. Each was determined to have normal 
Preyer reflexes. Examination of the middle ear 
during surgery revealed no evidence of pathology. 
Laser Doppler ~owme~er 
A Doppler system has recently been developed 
to measure blood flow using coherent laser light 
(Powers and Frayer, 1978; Stern, 1975). This tech- 
nique has been applied to skin and renal cortex 
and has been shown for these structures to provide 
a measure which correlates in a linear fashion with 
blood flow as measured via radioactive xenon 
clearance and radioactive microspheres (Holloway 
and Watkins, 1977; Oberg et al., 1979; Stern et al.. 
1977). 
The system uses a helium-neon laser light (632.8 
nm). Moving particles create a spectral shift in the 
reflected light. In the laser Doppler instrument the 
reading is proportional to the product of the veloc- 
ity of the red blood cells (RBCs) within the mea- 
surement volume and the volume fraction (number 
of RBCs) (Nilsson et al., 1980). The product of 
volume and velocity is referred to as flux. 
The Doppler probe is sensitive to reflected light 
in a volume of 1 nim3 (Bonner et al., 1981). In the 
skin the depth of penetration is up to 1.5 mm but 
has been judged to be effectively 1.0 rmn (Nilsson 
et al., 1980). It is not known what the effective 
depth of penetration is in the cochlea but is anti- 
cipated to be less than that observed in the less 
dense skin. Given the measurement volume, the 
probe placement, and the apparent depth of 
penetration, it is assumed that the laser Doppler 
measures blood flow in the following cochlear 
vessels: capillaries of the spiral ligament including 
those of the Scala vestibuli, the stria vascularis, 
vessels of the spiral prominence, initial segments 
of the collecting venules, and perhaps vessels of 
the basilar membrane and osseous spiral lamina. 
Several recent investigations suggest that the laser 
Doppler is a measure which is proportional to 
cochlear blood flow changes as influenced by 
catecholamines, angiotensin, carbon monoxide, 
and local cooling (Goodwin et al., 1985; Miller et 
al., 1983, 1985; Short et al,, 1984; Wright et al., 
1985). 
Surgical procedures 
Ketamine (110 mg/kg) and Xylazine (13 
mg/kg) were employed as the anesthetic. Supple- 
mental injections (20 : 1 Ketamine : Xylazine) were 
employed as needed. A mounting post was secured 
to the animal’s head with stainless-steel screws and 
dental acrylic. The trachea was cannulated to per- 
mit unrestricted breathing. Blood pressure was 
monitored by a Statham {Model P23Db) strain 
type pressure gauge, via a femoral artery cannula 
(Type MRE-040, micro-renathan, Braintree Scien- 
tific) which also permitted infusion of saline and 
nicotine solutions. The catheter was tapered by 
heating it in vegetable oil (140°C) for 20 s and 
then pulling it to the desired diameter. In this way 
the catheter could be inserted until the tip was at 
or near the junction of the femoral and descending 
aorta arteries. 
The bulla was opened via a ventral approach 
exposing the cochlea. The lateral wall mucosa was 
gently removed with a cotton pledgette to eliminate 
mucosal vasculature and to permit approximation 
of the measurement probe to the bony surface of 
the lateral wall of the basal turn. In all other 
respects the middle ear was left intact. The needle 
probe (O.D. 1.75 mm) of the laser Doppler flow- 
meter (Medpacific, LD-5000) was positioned over 
the stria vasculature as described previously 
(Goodwin et al., 1985; Miller et al., 1983; Short et 
al., 1984; Wright et al., 1985). A second Doppler 
flowmeter was positioned over a shaved portion of 
the animal’s abdomen to measure skin blood flow, 
Core temperature was maintained by means of a 
heating pad placed beneath the animal. The out- 
put of both flowmeters and the strain gauge was 
monitored via a Sanborn polygraph. 
Experirne~~~~ procedures and analyves 
Baseline measurements were obtained for blood 
pressure, cochlear and abdominal skin blood flow. 
Repeated observations were made on each of the 
nine animals. Bolus infusions of 0.25 ml saline 
(vehicle, n = 5) or nicotine (Sigma Chemicals) 
solutions at doses of 0.2 (n = 3), 0.1 (n = X), 0.05 
(n = 8) or 0.01 (n = 6) pg/kg of body weight 
were administered via the femoral artery cannula. 
The order of the saline and nicotine doses was 
random to reduce cumulative effects. Following 
each infusion all measures were permitted to re- 
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turn to the pre-infusion baseline and demonstrate 
stability for at least 10 min before subsequent 
injections. 
Each dependent measure (blood pressure, 
cochlear blood flow and skin blood flow) was 
quantified at six second intervals beginning 36 s 
prior to the onset of infusion and continued until 
all measures returned to baseline. The 6 measures 
taken prior to the infusion were averaged to pro- 
vide an estimate of baseline. All subsequent scores 
were then calculated as a proportion of that base- 
line. Adjacent pairs of scores were averaged and 
plotted in Figs. l-3. In each of these figures the 
pre-infusion baseline is equal to a proportion score 
of 1.00. 
Two additional measures were also calculated 
employing the 6 s scores. These were the score 
which represented the maximum deviation from 
baseline (either positive or negative) expressed as a 
proportion of baseline and the number of seconds 
until the first return to baseline for 12 s or more. 
These latter two measures were used for statistical 
analyses. These measures evidenced considerable 
heterogeneity of variance. The large differences in 
variance for the various conditions precluded 
meeting the assumptions for many statistical tests 
including analysis of variance and Duncan’s Mul- 
tiple Range test. Consequently t-tests were em- 
ployed to assess the significance of the differences 
between treatments. It should be noted, however, 
that similar statistical results were obtained when 
Duncan’s Multiple Range test was employed. 
Results 
The mean arterial pressure during baseline 
averaged 48 f 3.16 (SE.) mmHg. Fig. 1 displays 
the average blood pressure (expressed as propor- 
tion of baseline) for each condition as a function 
of time after injection. Saline had a minor elevat- 
ing effect on blood pressure while nicotine infu- 
sions resulted in major elevations in blood pres- 
sure above baseline. The largest of these increases 
was observed for the highest dose (0.2 pg) and 
peaked between 36 and 60 s after the injection. 
The other doses of nicotine, while producing 
greater elevations than saline, and smaller effects 
than the highest dose did not appear to differ from 
each other. Statistical analysis, however, failed to 
Fig. 1. Mean blood pressure plotted as proportion of baseline 
for saline and nicotine groups as a function of time after 
infusion. 
indicate significant differences between the saline 
and any of the nicotine treatments in either maxi- 
mum change or in duration. 
Fig. 2 displays the average skin blood flow for 
each of the treatment conditions. Skin blood flow 
varied slightly from baseline in the saline condi- 
tion. In the nicotine conditions, skin blood flow 
decreased relative to baseline. Further. the magni- 
tude of the effect increased with increasing doses. 
The maximum change from baseline for the saline. 
0.01, 0.05. 0.1 and 0.2 pg nicotine conditions 
Fig. 2. Skin blood flow plotted as proportion of baseline for 
saline and nicotine groups as a function of time after infusion. 
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averaged (&S.E.) 1.08 (0.02), 0.80 (0.04), 0.82 
(0.08), 0.79 (0.08) and 0.76 (OJO), respectively. The 
number of seconds until the first return to baseline 
averaged(+S.E.) 22.8 (5.8), 40.8 (6.9), 48.5 (11.11) 
69.8 (10.7) and 70.0 (17.7) in the saline 0.01, 0.05, 
0.1 and 0.2 pg nicotine conditions, respectively. 
Statistical analyses indicated that the saline condi- 
tion was significantly (P < 0.05 or less) different 
from each of the nicotine conditions both in the 
maximum effect and in the duration of the effect. 
Further, the 0.2 pg condition required signifi- 
cantly longer time for the first return to baseline 
than did the remaining nicotine conditions. 
Fig. 3 displays the average cochlear blood flow 
in proportion of baseline for each of the treatment 
conditions. Relatively minor changes were ob- 
served in the saline condition. The two lowest 
doses of nicotine resulted in the greatest elevation 
in cochlear blood flow and relatively slow returns 
to baseline. The 0.1 pg dose of nicotine resulted in 
an elevation comparable to that of the lower doses 
and appeared to return to baseline rapidly. In 
contrast the highest dose of nicotine (0.2 pg) re- 
sulted in a decrement in cochlear blood flow which 
was slow to occur and which was slow to return to 
baseline, The average maximum CBF ( + S.E.) was 
1.05 (O.Ol), 1.17 (0.02), 1.20 (0.07), 1.08 (0.10) and 
0.87 (0.19) for the saline, 0.01, 0.05, 0.1 and 0.2 pg 
nicotine conditions, respectively. The average 
number of seconds (*S.E.) until returning to 
Fig. 3. Cochlear btood flow plotted as proportion of baseline 
for saline and nicotine groups as a function of time after 
infusion. 
baseline was 32.6 (13.7), 55.0 (7.8). 63.1) (10.9), 
61.5 (8.1) and 92.0 (25.7) for the saline, 0.01, 0.05, 
0.1 and 0.2 pg nicotine conditions, respectively. 
The statistical analysis indicated that only the 0.01 
and 0.05 pg nicotine conditions resulted in devia- 
tions from baseline which were significantly (P -c 
0.05) greater than those for the saline condition. 
Further the maximum change observed in the 0.2 
fig nicotine condition was significantly different 
from the maximum change observed in the 0.05 
and 0.01 pg nicotine conditions but not different 
from the saline condition. The duration of the 
change was significantly greater in the 0.05, 0.1 
and 0.2 pg nicotine conditions than in the saline 
condition. 
Discussion 
The major observation of the current study was 
that moderate doses of nicotine elevate CBF to a 
greater extent than does saline and that that eleva- 
tion lasts longer than the changes induced by 
saline. The elevations in CBF noted in the mod- 
erate doses may be att~butable to systemic 
changes. That is, the changes in CBF noted in 
these conditions may be passive ones which are 
secondary to increased systemic blood pressure 
and cutaneous vasoconstriction. A similar conclu- 
sion has been reached by others (Goodwin et al., 
1985; Miller et al., 1983, 1985; Snow and Suga, 
1972; Suga and Snow, 1969; Wright et al., 1985). 
In the current results, however, blood pressure 
changes in response to nicotine were not statisti- 
cally significant while changes in skin and cochlear 
blood flow were. This observation detracts from 
the possibility of explaining CBF changes as being 
secondary to systemic blood pressure changes. 
Furthermore, the changes in CBF observed in 
the higher dose conditions of the current experi- 
ment may require another explanation. The failure 
of the 0.1 pg dose to elevate CBF to a level that 
was significantly greater than that observed in the 
saline condition, and the negative change in CBF 
observed for the 0.2 pg dose are not consistent 
with the changes observed in cutaneous blood flow 
or the direction of the changes in blood pressure. 
An explanation other than passive responsiveness 
secondary to systemic blood pressure is required 
for these higher dose effects. One possible ex- 
35 
planation relates to the ganglionic stimulating and 
blocking effect of nicotine (Taylor, 1980; Voile 
and Koelle, 1970). Since nicotine has both effects 
it is possible that the smaller change in the 0.1 pg 
condition and the negative change in the 0.2 pg 
condition represent the protracted blocking effect 
of nicotine on sympathetic ganglia. That is, the 
ganglionic receptors may have been saturated by 
the higher doses of nicotine which may then have 
blocked further effects of nicotine and inhibited 
normal mechanisms by which CBF is maintained. 
A second possible explanation for the unantic- 
ipated effects of the higher doses is that these 
findings may reflect some regional or local control 
of CBF independent of systemic changes. Such 
changes could reflect direct effects of nicotine on 
CBF or effects secondary to catecholamine release 
which in some manner control CBF. Previous 
authors have suggested that catecholamines do 
have a local vasoconstrictive effect within the ear 
(Muchnik et al., 1983). If CBF and cerebral blood 
flow are similarly controlled, then it is interesting 
to note that the dose which produced a decrement 
in CBF (0.2 yg) is the same dose for which Vatner 
et al. (1980) observed an initial increase and then a 
decrease in cerebral blood flow in dogs. 
While the current findings indicate that low to 
moderate doses of nicotine elevate cochlear blood 
flow, some cautions are warranted. The laser Dop- 
pler measures of cochlear blood flow require an 
anesthetized preparation. The blood pressures 
noted in the current results were somewhat lower 
than may be expected for normal resting blood 
pressures. The observed average baseline blood 
pressure was 48 mmHg. Other authors have re- 
ported that resting awake blood pressures in guinea 
pigs average 50--70 mmHg (Marshall and Hanna, 
1956; Muchnik et al., 1980). It is not known what 
effect anesthesia or reduced blood pressure may 
have on the current measures of cochlear blood 
flow. 
It should also be pointed out that the Doppler 
flowmeter provides a measure of flux: the product 
of red cell volume fraction and their mean veloc- 
ity. Thus, while the current findings indicate that 
low to moderate doses of nicotine elevate CBF, it 
is not known whether that elevation represents 
high blood cell velocity, greater volume fraction or 
both. Clarification of the difference may lead to 
clarification in the mechanism by which nicotine 
elevates CBF. 
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